{"url_path":"/sec/envb/8-k/2026-05-15/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/890821/0001493152-26-023345-index.html","accession_number":"0001493152-26-023345","cik":"0000890821","ticker":"ENVB","issuer_name":"Enveric Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/890821/0001493152-26-023345-index.html","primary_entity_key":"0000890821","primary_entity_name":"Enveric Biosciences, Inc."},"word_count":157,"has_tables":true,"body_markdown":"**Item\n2.02 Results of Operations and Financial Condition.**\n\n \n\nOn\nMay 15, 2026, Enveric Biosciences, Inc. issued a press release providing a corporate update and announcing its financial results for\nthe first quarter ended March 31, 2026. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by\nreference.\n\n \n\nIn\naccordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, that\nis furnished pursuant to this Item 2.02 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities\nExchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall\nnot be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended,\nor the Exchange Act, except as shall be expressly set forth by specific reference in such filing."}